glaxosmithkline biologicals s.a.
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for glaxosmithkline biologicals s.a. from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 50 transactions, with a transaction quantity of 1237312.75 and a transaction weight of 39555.2.
- Year Transactions Quantity Weight
- 2025 631 16300485.04 354696.26
- 2026 50 1237312.75 39555.2
Bill of lading data
< 1/15 >- Trade date 2026/03/21 B/L No. cec2026la030482
- Suppliers glaxosmithkline biologicals s.a. Buyers ministrio de salud publica
- POLs pty-tocumen-ciudad de panama PODs quito
- Supply area Panama Purchas area Ecuador
- Weight 2375kg Amount 810000
- Hs code 3002419000 Product tags ——
- Product description ROTAVIRUS VACCINE ORAL 2 DOSE SCHEDULE LIQUID ORAL APPLICATOR Expand
- Trade date 2026/03/21 B/L No. 004514128645
- Suppliers glaxosmithkline biologicals s.a. Buyers ministrio de salud publica
- POLs panama city PODs quito
- Supply area Panama Purchas area Ecuador
- Weight 5250kg Amount 31758
- Hs code Product tags ——
- Product description MANTENER DE 2 A 8 GRADOS Expand
- Trade date 2026/03/16 B/L No. 4600337104
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 4118kg Amount 50008491.23
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 82,944 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
- Trade date 2026/03/16 B/L No. 4600337129
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 4118kg Amount 50008491.23
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 82,944 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
- Trade date 2026/03/13 B/L No. 4600337132
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 4118kg Amount 49526237.31
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 82,944 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
- Trade date 2026/03/12 B/L No. 4600337133
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 4118kg Amount 49526237.31
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 82,944 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
- Trade date 2026/03/11 B/L No. 4600337136
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 4118kg Amount 49438851.52
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 82,944 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
- Trade date 2026/03/11 B/L No. 4600337135
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 4118kg Amount 49438851.52
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 82,944 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
- Trade date 2026/02/27 B/L No. 92003005878080
- Suppliers glaxosmithkline biologicals s.a. Buyers ministerio de salud y proteccion social
- POLs —— PODs bogota
- Supply area Belgium Purchas area Colombia
- Weight 2213.5kg Amount 754920
- Hs code 3002419000 Product tags ——
- Product description DO:I26103112, PEDIDO APO25-00022891, DECLARACION 1 DE 1, FACTURA(S) 13000215, // REGISTRO DE IMPORTACION REG-50020586-20260204N FECHA 2026-02-04; VISTO BUENO VINVIMA-26-0015530 FECHA 2026-02-03; NOS ACOGEMOS AL DECRETO 249 DE 2013, ARTICULO 1 DECRETO 272DE 2018 Y AL ARTICULO 477 DEL ESTATUTO TRIBUTARIO. VACUNAS PARA USO HUMANO. LAS DEMAS. DOCUMENTO OPS COL/AM/PRO/85.12 (E_P 00050_26) DEL 23-ENE-2026. PEDIDO: APO25-00022891. NOMBRE COMERCIAL: ROTARIX SUSPENSION ORAL, PRINCIPIO ACTIVO: ROTAVIRUS VIVOS ATENUADOS HUMANOS CEPA RIX4414. CONCENTRACION DEL PRINCIPIO ACTIVO: UNA DOSIS DE 1,5 ML CONTIENE ROTAVIRUS VIVOS ATENUADOS HUMANOS CEPA RIX4414 NO MENOS DE 10^6,0 CCID50. INDICACIONES TERAPEUTICAS: PREVENCION DE LA GASTROENTERITIS EN NIÑOS DE 6 A 24 SEMANAS DE EDAD CAUSADA POR ROTAVIRUS, ESQUEMA ORAL DE 2 DOSIS. FORMA FARMACEUTICA: SUSPENSION ORAL, PRODUCTO: VACUNA VIVA ATENUADA CONTRA GASTROENTERITIS CAUSADA POR ROTAVIRUS, ORIGEN: ROTAVIRUS VIVOS ATENUADOS HUMANOS CEPA RIX4414 CULTIVADOS EN CELULAS VERO, ASPECTO Expand
- Trade date 2026/02/27 B/L No. 92003005847358
- Suppliers glaxosmithkline biologicals s.a. Buyers ministerio de salud y proteccion social
- POLs —— PODs bogota
- Supply area Belgium Purchas area Colombia
- Weight 2213.5kg Amount 754920
- Hs code 3002419000 Product tags ——
- Product description DO:I26103113, PEDIDO APO25-00022892, DECLARACION 1 DE 1, FACTURA(S) 13000216, // REGISTRO DE IMPORTACION REG-50020596-20260204N FECHA 2026-02-04, VISTO BUENO VINVIMA-26-0015552 FECHA 2026-02-03; NOS ACOGEMOS AL DECRETO 249 DE 2013, ARTICULO 1 DECRETO 272DE 2018 Y AL ARTICULO 477 DEL ESTATUTO TRIBUTARIO. VACUNAS PARA USO HUMANO. LAS DEMAS. DOCUMENTO OPS COL/AM/PRO/85.12 (E_P 00051_26) DEL 23-ENE-2026. PEDIDO: APO25-00022892. NOMBRE COMERCIAL: ROTARIX SUSPENSION ORAL, PRINCIPIO ACTIVO: ROTAVIRUS VIVOS ATENUADOS HUMANOS CEPA RIX4414. CONCENTRACION DEL PRINCIPIO ACTIVO: UNA DOSIS DE 1,5 ML CONTIENE ROTAVIRUS VIVOS ATENUADOS HUMANOS CEPA RIX4414 NO MENOS DE 10^6,0 CCID50. INDICACIONES TERAPEUTICAS: PREVENCION DE LA GASTROENTERITIS EN NIÑOS DE 6 A 24 SEMANAS DE EDAD CAUSADA POR ROTAVIRUS, ESQUEMA ORAL DE 2 DOSIS. FORMA FARMACEUTICA: SUSPENSION ORAL, PRODUCTO: VACUNA VIVA ATENUADA CONTRA GASTROENTERITIS CAUSADA POR ROTAVIRUS, ORIGEN: ROTAVIRUS VIVOS ATENUADOS HUMANOS CEPA RIX4414 CULTIVADOS EN CELULAS VERO, ASPECTO Expand
- Trade date 2026/02/27 B/L No. 2080512
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs delhi
- Supply area England Purchas area India
- Weight —— Amount 177.93
- Hs code 30021290 Product tags ting,antiserum,influenza,cd
- Product description INFLUENZA ANTISERUM SAMPLES FOC NCV ONLY FOR TESTING PURPOSE AT CDTLINFLUENZA ANTISERUM SAMPLES FOC NCV ONLY FOR TESTING PURPO Expand
- Trade date 2026/02/27 B/L No. 3344350
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs mumbai (ex bombay)
- Supply area Belgium Purchas area India
- Weight —— Amount 504397.44
- Hs code 30024119 Product tags vaccine,jug,flor,bed,synflorix,pac sy,polysaccharide,occa,neumo
- Product description SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE ADSORBED I P LIST 2 SR NO 80 PAC SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VA Expand
- Trade date 2026/02/27 B/L No. 4305174
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs delhi
- Supply area England Purchas area India
- Weight —— Amount 177.93
- Hs code 30021290 Product tags ting,antigen,cd,influenza,seat
- Product description INFLUENZA ANTIGEN SAMPLES FOC NCV ONLY FOR TESTING PURPOSEAT CDTLINFLUENZA ANTIGEN SAMPLES FOC NCV ONLY FOR TESTING PURPOSE Expand
- Trade date 2026/02/24 B/L No. 4600337098
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 4118kg Amount 49794749.46
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 82,944 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
- Trade date 2026/02/24 B/L No. 4600337100
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline philippines inc.
- POLs —— PODs ninoy aquino international airport
- Supply area Belgium Purchas area Philippines
- Weight 515kg Amount 6182962.83
- Hs code 30024190000 Product tags influenza,flu,cf,pc,activa,vaccine
- Product description 10,368 PCK FLU.QIV SLCF +2N PH SH INACTIVATED INFLUENZAE VACCINE Expand
Partners
Total 92- Rank Company Transactions Per Detail
- 1 glaxosmithkline colombia s.a. colombiabuyer,they trade on 2026-01-23 805 12.14% >
- 2 ооо вортэкс russiabuyer,they trade on 2024-01-30 729 10.99% >
- 3 gsk biologicals north america united statesbuyer,they trade on 2019-02-05 557 8.40% >
- 4 тов глаксосміткляйн фармасьютікалсукраїна ukrainebuyer,they trade on 2024-04-29 506 7.63% >
- 5 gsk vx marietta united statesbuyer,they trade on 2025-03-29 283 4.27% > +View All
Products
Total 281- Products Transactions Per Detail
-
gh
252 24.88% > -
cod
190 18.76% > -
3m
156 15.4% > -
cf
148 14.61% > -
vial
129 12.73% >
+View All
Hscode rank
Total 288- HSCode Name Transactions Per Detail
- HS 30024190 189 18.66% >
- HS 3002419000 120 11.85% >
- HS 30024119 60 5.92% >
- HS 38229090 41 4.05% >
- HS 30021290 35 3.46% > +View All
Trading Area
Total 25- Area Transactions Per Detail
- united states 1178 17.77% >
- colombia 1090 16.44% >
- russia 950 14.33% >
- ukraine 726 10.95% >
- vietnam 520 7.84% > +View All
Port statistics
Total 47- Port Name Transactions Per Detail
- antwerp 1134 17.10% >
- bruxelles brussel 242 3.65% >
- bruxelles 120 1.81% >
- brussels 111 1.67% >
- brussel bruxelles 100 1.51% > +View All
glaxosmithkline biologicals s.a. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as gh，cod，3m.
According to the 52wmb.com global trade database, as of 2026-03-23, the company has completed 6631 international trades,
with its main trading regions covering united states，colombia,russia etc.
The core products include HS30024190，HS3002419000，HS30024119 etc,
often transported via antwerp，port bruxelles brussel, port bruxelles etc,
and its main trading partners are glaxosmithkline colombia s.a.，ооо вортэкс，gsk biologicals north america.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on glaxosmithkline biologicals s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool